Belgium· BE-AMP-SAM097142-00
Minims Oxybuprocaine Chlorhydrate 4 mg/ml
A oxybuprocaine product containing oxybuprocaine hydrochloride, registered in Belgium by Bausch + Lomb Ireland. The same ATC class is registered in 11 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Oxybuprocaine is registered in 11 of 19 countries.
Countries holding a registration under ATC S01HA02 (oxybuprocaine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Oxybuprocaine · ATC S01HA02
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Oxybuprocaine Hydrochloride
- Manufacturer
- Bausch + Lomb Ireland
- Country
- Belgium (BE)
- ATC code
- S01HA02
- ATC class
- Oxybuprocaine
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb0025916
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
40 interactions on record for oxybuprocaine.
Graded by severity as the source publishes them — 40 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxybuprocaine · interactions on record
40 records
- 40 moderate
Most severe, free to view
- MetoclopramideA03FA01moderate
- SulfamethizoleB05CA04moderate
- LidocaineC01BB01moderate
- Glyceryl trinitrateC01DA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Oxybuprocaine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenObupro 4 mg/ml Ögondroppar, lösningAgepha Pharma s.r.o.
- FinlandMinims Oxybuprocaine HydrochlorideBausch + Lomb Ireland Limited
- CzechiaBENOXIUNIMED PHARMA spol. s r.o., Bratislava
- NetherlandsMinims Oxybuprocainehydrochloride 4 mg/ml, oogdruppels, oplossingBausch + Lomb Ireland Limited
- IcelandNovainAgepha Pharma s.r.o.
- FranceCHLORHYDRATE D'OXYBUPROCAINE THEA 1,6 mg/0,4 ml, collyre en récipient unidoseTHEA
- NorwayOxibuprokain MinimsBAUSCH + LOMB IRELAND LIMITED
- PolandNovainAGEPHA Pharma s.r.o.
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Benoxinat Zur Anästhesie In Der Oto-Rhino-Laryngologie, Novain
- Bulgaria · Бенокси
- Czechia · Benoxi, Oxybuprocaine Olikla
- Germany · Conjuncain® Edo®, Novesine
- Denmark · Oftasen, Oxybuprocainhydrochlorid Agepha
- Estonia · Novain
- Spain · Oxibuprocaína Hidrocloruro Agepha
- Finland · Minims, Obupro 4 Mg/Ml Silmätipat, Liuos
- France · Cebesine, Chlorhydrate D’oxybuprocaine Thea
- United Kingdom (Northern Ireland) · Oxybuprocaine Hydrochloride Alfa Intes
- Croatia · Ophtesia
- Hungary · Humacain, Oxybuprocaine Hydrochloride Agepha
- Ireland · Oxybuprocaine Agepha
- Iceland · Novain
- Italy · Benoxinato Cloridrato Intes, Novesina
- Lithuania · Novain
- Luxembourg · Conjuncain Edo, Minims
- Latvia · Oxybuprocaine Hydrochloride Agepha 4 Mg/Ml
- Netherlands · Minims, Monofree
- Norway · Obupro, Oxibuprokain Minims Bausch + Lomb Ireland Limited
- Poland · Novain, 4 Mg/Ml,
- Portugal · Anestocil, Novain 4 Mg/Ml Colírio,
- Romania · Benoxi, Oftacain
- Sweden · Novain, Oxibuprokain Bausch & Lomb
- Slovakia · Benoxi, Oxybuprocaine Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc9529c2-64ca-4b4e-9781-b5414204e688 GET /v1/drugs/dc9529c2-64ca-4b4e-9781-b5414204e688?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye drops, solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Minims Oxybuprocaine Chlorhydrate 4 mg/ml",
"name_fr": "Minims Oxybuprocaine Chlorhydrate 4 mg/ml",
"name_nl": "Minims Oxybuprocaine Chlorhydrate 4 mg/ml",
"amp_code": "SAM097142-00",
"strengths": [
"4.0000",
"3.5800"
],
"pack_count": 3,
"substances": [
"Oxybuprocaine Hydrochloride",
"Oxybuprocaine"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Oxybuprocaine",
"authorisation_numbers": [
"BE097142"
]
}See everything about oxybuprocaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.